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ABSTRACT 
Objective: The objectives of the present study were to determine the prevalence of Potentially Inappropriate Medications and Adverse Drug 
Reactions in older adults and to collect doctors’ responses regarding the PIM list or any other criteria to treat older adults in India.  
Methods: This was an observational study conducted in different tertiary care hospitals of two districts, Erode and Salem after obtaining approval 
of the Institutional Ethics Committee. A sample of 250 older adults (60 y and above) and 97 doctors were included during the study period of 6 mo 
from February 2019 to July 2019. Inappropriate medications were identified by using 2019 updated Beer’s criteria. The causality of the adverse 
events was assessed by Naranjo Adverse Drug Reaction Probability Scale.  
Results: Out of the 250 prescriptions, only 86(34.4%) of the prescriptions were appropriate and 164(65.6%) were inappropriate. The most 
commonly inappropriate prescribed medications were diuretics, ranitidine, and tramadol. A total of 74 ADRs was observed in 74 patients. Of these, 
57(22.8%) ADRs were due to inappropriate medications listed in Beers criteria. There was a significant association between the occurrence of ADRs 
and the use of PIMs listed in 2019 updated Beer’s criteria [χ2 = 6.08, P = 0.013 (df = 1)].  
Conclusion: The study shows that there is a high prevalence of inappropriate medications and adverse drug reactions in hospitalized older adults. 
Beer’s criteria can be used as a guideline by the physicians while prescribing the drugs to the geriatric population.  
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INTRODUCTION 
Most developed countries have accepted the chronological age of 65 y 
as a definition of ‘elderly’ or ‘older person’ [1]. In January, 1999 the 
Government of India adopted ‘National Policy on Older Persons’ and 
this policy defines ‘senior citizen’ or ‘elderly’ as a person who is of 
age 60 y or above. The population ageing, started in the last century 
with developing countries, is now encircling developing countries 
too due to various reasons including better health care systems. 
Nearly, there are 104 million aged persons (aged 60 y or above) in 
India; 53 million females and 51 million males, consistent with the 
population census 2011. From 5.6% in 1961, the proportion has 
increased to 8.6% in 2011 [2]. The medications in which risks 
outweigh benefits are defined as Potentially Inappropriate 
Medications (PIMs). Inappropriate prescribing in the elderly 
population is a major public health issue, given its direct linkage to 
substantial morbidity, mortality and wastage of health resources that 
result from adverse drug reactions [3]. Appropriateness in healthcare 
has been defined as “the outcomes of a process of decision making that 
maximizes net health gains within society’s available resources”. 
Appropriate prescribing also associated with a reduction of over-use, 
under-use and misuse of treatment [4]. 
Prescribing quality for elderly patients can be improved by reducing 
irrational and inappropriate prescribing, thereby resulting in better 
health care. Therefore, assessment tools for the appropriateness of 
elderly pharmacotherapy are the essential fundamentals in defining 
whether an improvement in prescribing is needed. Different screening 
tools prepared for the assessment of the appropriateness of 
prescription and some of them are being used for assessment of the 
appropriateness of prescription [3]. The Beer’s criteria firstly 
published in 1991, to determine potentially inappropriate prescribing 
in elderly nursing home residents [5]. The 2019 American Geriatric 
Society (AGS) Beer’s criteria update contributes to the critically 
important evidence base and discussion of medications to avoid in 
older adults and the need to improve medication use in older adults. It 
includes 30 individual criteria of medications or medication classes to 
be avoided in older adults and 16 criteria specific to more than 40 
medications or medication classes that should be used with caution or 
avoided in certain diseases or conditions. The 2019 AGS Beer’s criteria 
is the third such update by the AGS and the fifth update of the AGS 
Beer’s criteria since their original release [6]. 
MATERIALS AND METHODS 
Study design and ethical considerations 
This was an observational Study conducted in the inpatient 
departments of different tertiary care hospitals of two districts, 
Erode and Salem after obtaining approval of the Institutional Ethics 
Committee (REF NO: EC/PHARM D/2019–01). 
Sample size 
In this study 250 patients were enrolled, also 97 doctor’s responses 
regarding the PIM list. 
Study duration 
This study was conducted for a period of 6 mo from February 2019 
to July 2019. 
Data collection 
Patients who met the inclusion criteria were enrolled in the study. All 
information relevant to the study was collected from case records. The 
demographic characters, co-morbid conditions, drug dose, frequency, 
adverse drug reactions were documented in the pro forma. Responses 
from doctors are collected in a self-prepared questionnaire. Doctors of 
all departments were also included in the study.  
Inclusion Criteria 
Patients with 60 y or above and all inpatients were included irrespective 
of their disease conditions, doctors of all departments were included. 
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Exclusion Criteria 
Patients below 60 y and outpatients, doctors who were not willing to 
participate in the study and gynecology, pediatrics department were 
excluded. 
Data analysis and interpretations 
The study subjects were described in respect of their demographic 
profiles according to their age and gender. The continuous variables 
were described in terms of mean with standard deviation. The 
categorical variables were described in terms of percentages. In 
respect of categorical variables, the χ2
RESULTS 
 (Chi-square) test was taken 
into account. The P-values less than or equal to 0.05 (P≤0.05) w ere 
fixed as the level of significance. 
A total of 250 hospitalized older adults was studied. The mean age of 
the study population was 71.6±7.0 y (table 1). The study population 
comprised of males 144 (57.6%) and females 106 (42.4%) (fig. 1). A 
total of 690 diseases was diagnosed in 250 studied subjects, of 
which 73 (29.2%) patients were diagnosed with three diseases/co-
morbidities followed by 63 (25.2%) with four or more, 58 (23.2%) 
patients with two and 56 (22.4%) with one disease/co-morbidities. 
The five most frequent diseases diagnosed were Hypertension 121 
(17.53%), followed by Diabetes Mellitus 120 (17.39%), Coronary 
Artery Disease 26 (3.76%), Chronic kidney disease 23 (3.33%) and 
COPD 18 (2.60%) (table 2). 
 
Fig. 1: Gender wise distribution 
  
Table 1: Age-wise distribution 
S. No. Age group (years) Frequency (N=250) Percentage (%) mean±SD 
1 60-69 80 32.0 63.4±2.5 
2 70-79 141 56.4 73.4±2.9 
3 80-89 26 10.4 82.4±2.2 
4 ≥90 3 1.2 93.3±2.9 
 Total 250 100.0 71.6±7.0 
 
Table 2: Most common diagnosis 
S. No. Diagnosis Frequency Percentage (%) 
1.  Hypertension 121 17.53 
2.  Diabetes Mellitus 120 17.39 
3.  Coronary Artery Disease 26 3.76 
4.  Chronic Kidney Disease 23 3.33 
5.  COPD 18 2.60 
 
A total of 2500 drugs was prescribed in 250 prescriptions with a 
maximum of 5-9 drugs 109 (43.6%), followed by 10-14 drugs 85 
(34%), 15-20 drugs 38 (15.2%), 1-4 drugs 15 (6%) and 20 or more 
drugs 3 (1.2%). Out of the 2500 prescribed drugs, 297 (11.88%) PIM 
drugs were identified (table 3). The most commonly identified PIM 
drug were Diuretics 48 (16.16%) and Ranitidine 42 (14.14%), 
followed by Tramadol 23 (7.74%), Spironolactone 21 (7.07%), 
Digoxin 17 (5.72%), Glimepiride 16 (5.38%), Diclofenac and 
Alprazolam 15 (5.05%), Enoxaparin and Levetiracetam 12 (4.04%), 
and the remaining drugs were occurred as single digits. Out of the 
250 prescriptions, only 86 (34.4%) of the prescriptions were 
appropriate and 164 (65.6%) were inappropriate. 
 
Table 3: Percentage distribution of PIM drugs 
Potentially inappropriate medication (PIM) use according to 2019 updated Beer's Criteria 
Organ system, therapeutic category Drugs Instances, N =297 











Anti-parkinsonian agents Trihexyphenidyl 1(0.33) 
Antispasmodic Dicyclomine 1(0.33) 
Anti-infective Nitrofurantoin 1(0.33) 
Cardiovascular Prazosin 6(2.02) 










Central Nervous System Amitriptyline 3(1.01) 













Endocrine Insulin, sliding scale 8(2.69) 
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PIMS due to varying level of kidney function 
Anti-infective Ciprofloxacin 1(0.33) 










Gastrointestinal Ranitidine 42(14.14) 
 
Out of 2500 drugs prescribed, 77 drugs (3.08%) were causing 
ADR. The most common ADR drugs were observed under anti-
diabetic drugs 18(23.37%), followed by Cardiovascular drugs 14 
(18.18%), drugs acting on Central nervous system and analgesics 
9 (11.68%), Gastrointestinal drugs 8 (10.38%), Antimicrobial 
drugs 5 (6.49%), Anti-cancer drugs and others 4 (5.19%), 
Respiratory drugs 3 (3.89%), Anti-hyperlipidemic drugs 2 (2.59%) 
and Anti-tubercular drugs 1 (1.29%). The most common organ 
system involved was Gastrointestinal 29 (39.18%), followed by 
endocrine 14 (18.91%), others 10 (13.51%), cardiovascular 9 
(12.16), Central nervous system 8 (10.81%) and dermatology 4 
(5.40%) (table 4). 
  
Table 4: Percentage distribution of ADR pattern among study subjects 
S. No. Organ system involved Frequency Percentage (%) 
1 Gastrointestinal 29 39.18 
2 Endocrine 14 18.91 
3 Cardiovascular 9 12.16 
4 Central nervous system 8 10.81 
5 Dermatologic 4 5.40 
6 Others 10 13.51 
 
A total of 74 ADRs was observed in 74 patients (29.6%). Of these, 57 
(22.8%) ADRs were due to PIMs listed in Beers criteria and 17 (6.8%) 
ADRs were due to other drugs. Of the 176 (70.4%) patients not having 
any ADRs, 107 (42.8%) patients were receiving PIMs and 69 (27.6%) 
patients were not receiving any PIMs during their hospital stay (fig. 2). 
There was a significant association between the occurrence of ADRs 
and the use of PIMs listed in 2019 updated Beer’s criteria [χ2 = 6.08, P 
= 0.013 (df = 1)]. The severity assessment of ADR was assessed using 
the Naranjo scale. Out of the 74 observed ADRs, 48.6% (36) were 
probable ADR and 54.1% (38) was possible ADR. 
 
 
Fig. 2: ADRs and use of PIMs among study subjects 
 
A total of 97 doctors’ responses regarding PIM criteria or any other 
guidelines available in India to treat older adults were collected. 
Only 8.2% (8) doctor’s responded that they are aware of criteria to 
treat older adult in India and 91.8% (89) of the doctors were not 
aware of any such criteria. Only 6.2 % (6) of the doctors informed 
that the PIM list or other guidelines were available and 93.8% (91) 
replied as not available. 95.9% (93) of doctor’s replied that there is a 
need of PIM criteria in India and 4.1% (4) replied that there is no 
need of such criteria. Among the doctors 98.9% (96) replied, the PIM 
will improve the clinical practice and only 1.1% (1) were replied 
negatively. Among the doctors 98.9% (96) had opined that the PIM 
list will reduce the chance of ADR and only 1.1% (1) opined 
negatively. The results were statistically very highly significant 
(P<0.001) (table 5). 
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Table 5: PIM list can reduce the chance of ADR and improve the treatment option 
Response Frequency Percentage (%) Χ Significance 2 
YES 96 98.9 93.041 
df=1 
P<0.001 
NO 1 1.1 
TOTAL 97 100.0 
 
DISCUSSION 
The fastest-growing population in the 21st 
Many primary care physicians possess a poor knowledge of 
potentially inappropriate medications and are unaware of 
prescribing guidelines and screening tools for PIM use such as Beers 
Criteria [8]. 
century is the people 
over 85 y of age depicting aging of the population [7]. The aging 
population is accompanied by the increasing presence of diseases 
and so there is increased drug utilization by the older population. 
The elderly population is also vulnerable to adverse drug events 
which often can be prevented by detecting risk factors.  
The current study included a total of 250 older patients (aged 60 y 
and above), of which the age group distribution between 70-79 y is 
constituted with 141 (56.4%), which is the highest percentage, 
whereas the study conducted by Senthilvel R et al. [9] reports that 
84 (42%) of the patients belong to the age group of 65-69 y. The 
male patients (57.6%) were more prevalent than female patients. 
Similar gender prevalence was found in studies carried out in older 
inpatients by Rohit SR et al. [10] (59.8%), Harugeri A et al. [11] 
(60.6%). While some studies by Jhaveri et al. [12] (52.12%), Shah et 
al. [13] (59.32%) showed a higher prevalence of female patients. 
In this study, most of the patients were diagnosed to have three 
diseases/co-morbidities 73 (29.2%), while a prospective study by 
Vishwas HN et al. [14] reported that most patients diagnosed to have 
two diseases (3.7%). In this study, Hypertension (17.53%), Diabetes 
Mellitus (17.39%), Coronary Artery Disease (3.76%), Chronic Kidney 
Disease (3.33%) and COPD (2.60%) were the diagnosis of the most 
common disease. Studies conducted in medicine wards by Harugeri et 
al. [11] also reported Hypertension (41.5%), Diabetes (34%) and 
COPD (18.5%) as the most frequent diagnoses in the study population. 
Polypharmacy is one of the risk factor for PIM use and adverse drug 
events. The present study shows that 43.6% patients were prescribed 
with 5 to 9 drugs. While a study conducted by Rohit SR et al. [10] 
reported 54.4% patients were prescribed with 10 or more drugs.  
The prevalence of PIM use among hospitalized older adults in the 
present study was found to be 65.6%, which is higher than that 
reported by Rohit SR et al. [10] (32.14%), Harugeri et al. [11] 
(23.5%) and Shah et al. [13] (29.3%). The commonly used PIMs 
were diuretics (16.16%) and ranitidine (14.14%). While studies 
conducted by Rohit SR et al. [10] reported the most commonly used 
PIMs as clonidine (19.6%), benzodiazepines (15.8%), insulin sliding 
scale (15.7%) and prazosin (9.8%). In our study, only 34.4% of the 
prescriptions were appropriate and 65.6% were inappropriate, 
whereas in a study conducted by Senthilvel et al. [9], 64.5% 
prescriptions were appropriate and 35.5% were inappropriate. 
In this study, the majority of the ADRs were caused by anti-diabetic 
drugs (23.37%) whereas in a study conducted by Jayanthi et al. [15] 
reports that the majority of ADRs were caused by Antimicrobials 
(22.5%). A total of 74 ADRs in 74(29.6%) patients were observed in 
the present study, which was higher than reported by Rohit SR et al. 
[10] (26.7%). While a higher prevalence of ADRs was reported by 
Harugeri et al. [11] (35.9%) among elderly patients. The most 
common organ system involved was gastrointestinal 29 (39.18%), 
whereas in a study conducted by Jayanthi et al. [15] reported 
dermatological side effects 34.83% as the most common organ 
system affected.  
The 57(22.8%) ADRs were due to medications listed in Beer’s 
criteria due to PIM use. There was a significant association between 
the occurrence of ADRs and the use of PIMs listed in 2019 updated 
Beer’s criteria [χ2 = 6.08, P = 0.013 (df = 1)]. While in study 
conducted by Rohit SR et al.[10] and Harugeri et al. [11] reported 
that the medications other than listed in Beer’s criteria were more 
likely to be associated with ADRs. 
Among 97 doctors, most of them responded that there are no 
specific criteria in India to treat older adults and there is a need of 
PIM criteria in India in order to improve the quality of life in older 
adults. 
CONCLUSION 
The current study could assess the prescribing patterns of medicines 
in the geriatrics according to Beer’s criteria 2019. The study report 
shows that the prevalence of PIM is increasing and PIM drugs are 
causing ADRs. The inappropriate medication use can be avoided by 
using Beer’s criteria 2019. Most of the doctors said that there are no 
PIM list or any other guidelines available to treat older adults in 
India and opined that introducing PIM list can improve the quality of 
life of older adults. Beer’s criteria can be used as a guideline by the 
physicians while prescribing the drugs to the geriatric population. 
LIMITATIONS 
• We planned to check the self-medication practices among the 
older adults, but the patients were incorporative for that and didn’t 
get any responses. 
• We planned to take responses from 120 doctors, but it gets 
limited to 97; the major problem with the doctors was they were so 
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